These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35369867)

  • 1. KMSubtraction: reconstruction of unreported subgroup survival data utilizing published Kaplan-Meier survival curves.
    Zhao JJ; Syn NL; Tan BKJ; Yap DWT; Teo CB; Chan YH; Sundar R
    BMC Med Res Methodol; 2022 Apr; 22(1):93. PubMed ID: 35369867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low Programmed Death-Ligand 1-Expressing Subgroup Outcomes of First-Line Immune Checkpoint Inhibitors in Gastric or Esophageal Adenocarcinoma.
    Zhao JJ; Yap DWT; Chan YH; Tan BKJ; Teo CB; Syn NL; Smyth EC; Soon YY; Sundar R
    J Clin Oncol; 2022 Feb; 40(4):392-402. PubMed ID: 34860570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IPDfromKM: reconstruct individual patient data from published Kaplan-Meier survival curves.
    Liu N; Zhou Y; Lee JJ
    BMC Med Res Methodol; 2021 Jun; 21(1):111. PubMed ID: 34074267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of Oral SERDs in the treatment of ER+, HER2 - metastatic breast cancer, a stratified analysis of the ESR1 wild type and mutant subgroups.
    Wong NZH; Yap DWT; Ong RJM; Zhao JJ; Chan YH; Tey JCS; Sundar R; Lim JSJ; Dawood SS
    Ann Oncol; 2023 Oct; ():. PubMed ID: 37871699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves.
    Guyot P; Ades AE; Ouwens MJ; Welton NJ
    BMC Med Res Methodol; 2012 Feb; 12():9. PubMed ID: 22297116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-linear optimisation method to extract summary statistics from Kaplan-Meier survival plots using the published P value.
    Irvine AF; Waise S; Green EW; Stuart B
    BMC Med Res Methodol; 2020 Oct; 20(1):269. PubMed ID: 33126853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating hazard ratios from published Kaplan-Meier survival curves: A methods validation study.
    Saluja R; Cheng S; Delos Santos KA; Chan KKW
    Res Synth Methods; 2019 Sep; 10(3):465-475. PubMed ID: 31134735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a gene expression signature predicting survival in oral cavity squamous cell carcinoma using Monte Carlo cross validation.
    Schomberg J; Ziogas A; Anton-Culver H; Norden-Krichmar T
    Oral Oncol; 2018 Mar; 78():72-79. PubMed ID: 29496061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of gastric cancer survival: using an artificial hierarchical neural network.
    Amiri Z; Mohammad K; Mahmoudi M; Zeraati H; Fotouhi A
    Pak J Biol Sci; 2008 Apr; 11(8):1076-84. PubMed ID: 18819544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualizing Time-Varying Effect in Survival Analysis: 5 Complementary Plots to Kaplan-Meier Curve.
    Huang Q; Tian C
    Oxid Med Cell Longev; 2022; 2022():3934901. PubMed ID: 35391933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.
    Lueza B; Rotolo F; Bonastre J; Pignon JP; Michiels S
    BMC Med Res Methodol; 2016 Mar; 16():37. PubMed ID: 27025706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Augmenting the logrank test in the design of clinical trials in which non-proportional hazards of the treatment effect may be anticipated.
    Royston P; Parmar MK
    BMC Med Res Methodol; 2016 Feb; 16():16. PubMed ID: 26869168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monte Carlo approaches to frequentist multiplicity-adjusted benefiting subgroup identification.
    Schnell PM
    Stat Methods Med Res; 2021 Apr; 30(4):1026-1041. PubMed ID: 33256562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate permutation test to compare survival curves for matched data.
    Galimberti S; Valsecchi MG
    BMC Med Res Methodol; 2013 Feb; 13():16. PubMed ID: 23399031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of subgroup analyses in multinational clinical trials: experiences from the MERIT-HF trial.
    Wedel H; Demets D; Deedwania P; Fagerberg B; Goldstein S; Gottlieb S; Hjalmarson A; Kjekshus J; Waagstein F; Wikstrand J;
    Am Heart J; 2001 Sep; 142(3):502-11. PubMed ID: 11526365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of induction selection chemotherapy vs primary surgery for patients with advanced oral cavity carcinoma.
    Chinn SB; Spector ME; Bellile EL; Rozek LS; Lin T; Teknos TN; Prince ME; Bradford CR; Urba SG; Carey TE; Eisbruch A; Wolf GT; Worden FP; Chepeha DB
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):134-42. PubMed ID: 24370563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monte Carlo based IMRT dose verification using MLC log files and R/V outputs.
    Luo W; Li J; Price RA; Chen L; Yang J; Fan J; Chen Z; McNeeley S; Xu X; Ma CM
    Med Phys; 2006 Jul; 33(7):2557-64. PubMed ID: 16898460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple-imputation for measurement-error correction.
    Cole SR; Chu H; Greenland S
    Int J Epidemiol; 2006 Aug; 35(4):1074-81. PubMed ID: 16709616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo methods in clinical research: applications in multivariable analysis.
    Concato J; Feinstein AR
    J Investig Med; 1997 Aug; 45(6):394-400. PubMed ID: 9291696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of methods for estimating the attributable risk in the context of survival analysis.
    Gassama M; Bénichou J; Dartois L; Thiébaut AC
    BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.